CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitness.
Saved in:
| Title: | CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitness. |
|---|---|
| Authors: | Romero-Moya D; Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Torralba-Sales E; Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Calvo C; Department of Physiological Sciences, Genetics Section, School Of Medicine, University of Barcelona, L'Hospitalet de Llobregat, Spain.; Josep Carreras Leukaemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain., Marin-Bejar O; Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.; Germans Trias i Pujol Health Science Research Institute (IGTP), Cancer Program, Badalona, Catalonia, Spain., Magallon-Mosella M; Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Distefano M; Department of Hematology and Oncology, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Deu, Barcelona, Spain., Pera J; Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Castaño J; Hospital Sant Joan de Deu Advanced Therapies Platform, SJD Pediatric Cancer Center Barcelona (PCCB) building, Barcelona, Spain., De Giorgio F; Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Gonzalez J; Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Programa de Investigación en Cáncer, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain., Iglesias A; Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Programa de Investigación en Cáncer, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain., Berenguer-Balaguer C; Department of Medicine and Life Sciences, Endocrine Regulatory Genomics, Universitat Pompeu Fabra (UPF), Barcelona, Spain., Schilling M; Gene Regulation of Cell Identity Lab, Neurosciences Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Spain.; Department of Genetics, Microbiology and Statistics, Faculty of Biology, University of Barcelona, Barcelona, Spain., Plass M; Gene Regulation of Cell Identity Lab, Neurosciences Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Spain.; Physiological Sciences Department, Faculty of Medicine and Health Sciences, University of Barcelona, L'Hospitalet del Llobregat, Spain., Pasquali L; Department of Medicine and Life Sciences, Endocrine Regulatory Genomics, Universitat Pompeu Fabra (UPF), Barcelona, Spain., Català A; Department of Hematology and Oncology, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Deu, Barcelona, Spain.; Instituto de Salud Carlos III, Biomedical Network Research Centre on Rare Diseases, Madrid, Spain., Molina O; Department of Physiological Sciences, Genetics Section, School Of Medicine, University of Barcelona, L'Hospitalet de Llobregat, Spain.; Josep Carreras Leukaemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain., Wlodarski MW; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA., Bigas A; Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Programa de Investigación en Cáncer, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain., Giorgetti A; Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain. agiorgetti@idibell.cat.; Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Barcelona University, Barcelona, Spain. agiorgetti@idibell.cat.; Center for Networked Biomedical Research on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain. agiorgetti@idibell.cat. |
| Source: | Leukemia [Leukemia] 2025 Dec; Vol. 39 (12), pp. 3015-3025. Date of Electronic Publication: 2025 Sep 15. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40954215 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitness. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Romero-Moya+D%22">Romero-Moya D</searchLink>; Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Torralba-Sales+E%22">Torralba-Sales E</searchLink>; Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Calvo+C%22">Calvo C</searchLink>; Department of Physiological Sciences, Genetics Section, School Of Medicine, University of Barcelona, L'Hospitalet de Llobregat, Spain.; Josep Carreras Leukaemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Marin-Bejar+O%22">Marin-Bejar O</searchLink>; Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.; Germans Trias i Pujol Health Science Research Institute (IGTP), Cancer Program, Badalona, Catalonia, Spain.<br /><searchLink fieldCode="AU" term="%22Magallon-Mosella+M%22">Magallon-Mosella M</searchLink>; Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Distefano+M%22">Distefano M</searchLink>; Department of Hematology and Oncology, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Deu, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Pera+J%22">Pera J</searchLink>; Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Castaño+J%22">Castaño J</searchLink>; Hospital Sant Joan de Deu Advanced Therapies Platform, SJD Pediatric Cancer Center Barcelona (PCCB) building, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22De+Giorgio+F%22">De Giorgio F</searchLink>; Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gonzalez+J%22">Gonzalez J</searchLink>; Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Programa de Investigación en Cáncer, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Iglesias+A%22">Iglesias A</searchLink>; Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Programa de Investigación en Cáncer, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Berenguer-Balaguer+C%22">Berenguer-Balaguer C</searchLink>; Department of Medicine and Life Sciences, Endocrine Regulatory Genomics, Universitat Pompeu Fabra (UPF), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Schilling+M%22">Schilling M</searchLink>; Gene Regulation of Cell Identity Lab, Neurosciences Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Spain.; Department of Genetics, Microbiology and Statistics, Faculty of Biology, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Plass+M%22">Plass M</searchLink>; Gene Regulation of Cell Identity Lab, Neurosciences Program, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Spain.; Physiological Sciences Department, Faculty of Medicine and Health Sciences, University of Barcelona, L'Hospitalet del Llobregat, Spain.<br /><searchLink fieldCode="AU" term="%22Pasquali+L%22">Pasquali L</searchLink>; Department of Medicine and Life Sciences, Endocrine Regulatory Genomics, Universitat Pompeu Fabra (UPF), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Català+A%22">Català A</searchLink>; Department of Hematology and Oncology, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Deu, Barcelona, Spain.; Instituto de Salud Carlos III, Biomedical Network Research Centre on Rare Diseases, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Molina+O%22">Molina O</searchLink>; Department of Physiological Sciences, Genetics Section, School Of Medicine, University of Barcelona, L'Hospitalet de Llobregat, Spain.; Josep Carreras Leukaemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Wlodarski+MW%22">Wlodarski MW</searchLink>; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.<br /><searchLink fieldCode="AU" term="%22Bigas+A%22">Bigas A</searchLink>; Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Programa de Investigación en Cáncer, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Josep Carreras Leukemia Research Institute (IJC), Badalona, Spain.<br /><searchLink fieldCode="AU" term="%22Giorgetti+A%22">Giorgetti A</searchLink>; Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain. agiorgetti@idibell.cat.; Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Barcelona University, Barcelona, Spain. agiorgetti@idibell.cat.; Center for Networked Biomedical Research on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain. agiorgetti@idibell.cat. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2025 Dec; Vol. 39 (12), pp. 3015-3025. <i>Date of Electronic Publication: </i>2025 Sep 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40954215 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41375-025-02771-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3015 Titles: – TitleFull: CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitness. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Romero-Moya D – PersonEntity: Name: NameFull: Torralba-Sales E – PersonEntity: Name: NameFull: Calvo C – PersonEntity: Name: NameFull: Marin-Bejar O – PersonEntity: Name: NameFull: Magallon-Mosella M – PersonEntity: Name: NameFull: Distefano M – PersonEntity: Name: NameFull: Pera J – PersonEntity: Name: NameFull: Castaño J – PersonEntity: Name: NameFull: De Giorgio F – PersonEntity: Name: NameFull: Gonzalez J – PersonEntity: Name: NameFull: Iglesias A – PersonEntity: Name: NameFull: Berenguer-Balaguer C – PersonEntity: Name: NameFull: Schilling M – PersonEntity: Name: NameFull: Plass M – PersonEntity: Name: NameFull: Pasquali L – PersonEntity: Name: NameFull: Català A – PersonEntity: Name: NameFull: Molina O – PersonEntity: Name: NameFull: Wlodarski MW – PersonEntity: Name: NameFull: Bigas A – PersonEntity: Name: NameFull: Giorgetti A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1476-5551 Numbering: – Type: volume Value: 39 – Type: issue Value: 12 Titles: – TitleFull: Leukemia Type: main |
| ResultId | 1 |